Uroxatral
- Product NDC
- 59212-200
- 11-digit product format
- 592120200
- Labeler code
- 59212
- Product ID
- 59212-200_ffbc758d-7556-4269-8947-baa7ddb88541
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alfuzosin HCl
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Advanz Pharma (US) Corp.
- Application
- NDA021287
- Marketing category
- NDA
- Marketing start
- 2013-06-03
- Substance
- ALFUZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Uroxatral
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALFUZOSIN HYDROCHLORIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 75046A1XTN |
| Rxcui | 861132, 861134 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59212-200-10 | Uroxatral | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 9 |
| 59212-200-30 | Uroxatral | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 9 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| alfuzosin hydrochloride | ACTIVE INGREDIENT | 75046A1XTN | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| alfuzosin | ACTIVE MOIETY | 90347YTW5F | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| ethylcellulose (100 mpa.s) | INACTIVE INGREDIENT | 47MLB0F1MV | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| ferric oxide yellow | INACTIVE INGREDIENT | EX438O2MRT | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| hydrogenated castor oil | INACTIVE INGREDIENT | ZF94AP8MEY | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| povidones | INACTIVE INGREDIENT | FZ989GH94E | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59212-200 | UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [ADVANZ PHARMA (US) CORP.] | 9 | Current NDC, Legacy NDC, 2 package rows | 20250103_9fc7f119-f36b-44cf-945d-940160f3afe3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59212-200-10 | 59212020010 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-10) | 2013-06-03 | 0000-00-00 | No | No | Current |
| 59212-200-30 | 59212020030 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-30) | 2019-01-18 | 0000-00-00 | No | No | Current |